Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Department of Health and Human Services
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project w
Funding
Award size
Not specified
Type
Cooperative Agreement
Dates
Deadline
Later
Posted
10/01/2024
Closes
2027-08-18
Eligibility
Eligibility
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal governments (Federally recognized)State governmentsCounty governmentsPublic housing authorities/Indian housing authoritiesFor profit organizations other than small businessesSmall businessesCity or township governmentsNative American tribal organizations (other than Federally recognized tribal governments)Independent school districtsPrivate institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)Special district governmentsPublic and State controlled institutions of higher educationNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Program
Funding area
Education - EDEnvironment - ENVHealth - HL
Opportunity #
PAR-24-293
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov